- Home
- IPHA vs CHN Comparison
IPHA vs CHN Comparison
Compare IPHA & CHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- CHN
- Stock Information
- Founded
- IPHA 1999
- CHN 1992
- Country
- IPHA France
- CHN United States
- Employees
- IPHA N/A
- CHN N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- CHN Investment Managers
- Sector
- IPHA Health Care
- CHN Finance
- Exchange
- IPHA Nasdaq
- CHN Nasdaq
- Market Cap
- IPHA 160.1M
- CHN 128.4M
- IPO Year
- IPHA 2019
- CHN N/A
- Fundamental
- Price
- IPHA $2.38
- CHN $12.21
- Analyst Decision
- IPHA Strong Buy
- CHN
- Analyst Count
- IPHA 1
- CHN 0
- Target Price
- IPHA $11.00
- CHN N/A
- AVG Volume (30 Days)
- IPHA 31.8K
- CHN 31.8K
- Earning Date
- IPHA 03-27-2025
- CHN 01-01-0001
- Dividend Yield
- IPHA N/A
- CHN 0.19%
- EPS Growth
- IPHA N/A
- CHN N/A
- EPS
- IPHA N/A
- CHN N/A
- Revenue
- IPHA $20,831,349.00
- CHN N/A
- Revenue This Year
- IPHA $209.83
- CHN N/A
- Revenue Next Year
- IPHA $83.96
- CHN N/A
- P/E Ratio
- IPHA N/A
- CHN N/A
- Revenue Growth
- IPHA N/A
- CHN N/A
- 52 Week Low
- IPHA $1.29
- CHN $9.00
- 52 Week High
- IPHA $3.51
- CHN $12.98
- Technical
- Relative Strength Index (RSI)
- IPHA 71.42
- CHN 51.39
- Support Level
- IPHA $2.13
- CHN $12.00
- Resistance Level
- IPHA $2.34
- CHN $12.51
- Average True Range (ATR)
- IPHA 0.14
- CHN 0.32
- MACD
- IPHA 0.04
- CHN 0.08
- Stochastic Oscillator
- IPHA 90.07
- CHN 54.86
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About CHN China Fund Inc. (The)
CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.